All Type of News
“Hallow market” with unnecessary large-scale pharmaceutical patent expirations
The pharmaceutical industry have not been satisfied even with patent expirations of large original pharmaceutical products. In particular, it was indicated that separation between the management and medical representa...
GSK’s Cervarix became the top of ‘Female VaccineThe GSK’s(Yoo-seok Hong, Korean Branch President) uterine cervical cancer preventive vaccines, ‘Cervarix,’ has acquired additional approval for indication of vaginal intra-epith...
|
Top domestic pharmaceutical companies increased 10% up in sales
As a series of unfavorable factors coincided, such as the governmental drug price restriction and the MERS crisis, weakening of domestic pharmaceutical companies’ management has been suggested, but their external form...
Large pharmaceutical product production slump
While the slowdown effect of overall pharmaceutical product production has lasted, production of large complete pharmaceutical products has not been able to get away from the slowdown. It was interpreted as reflection...
Expansion of all the diabetes treatments’ insurance benefits, solving doctors’ dilemmas
Although DPP-4 inhibitors, SGLT-2 inhibitors, basal insulin and GLP-1 analogues have different mechanisms, they are all used to cure diabetes.
These treatments, however, are practically included in the insurance bene...
Pfizer Korea announces the ERP todayAs starting the Early Retirement Program(ERP), Pfizer Korea is going to enter a condition of the labor-management conflict over the ERP.
According to the industry concerned on ...
|
The ‘PPI medicine’ market exceeded KRW 300 billion
Usage of PPI(proton-pump inhibitor) drugs, well-known reflux esophagitis treatments, is continuously increasing every year.
The annual increase rate was 9.7% for the past 5 years, and their prescriptions exceeded KRW...
The most domestically selling meningococcemia vaccine, ‘Menveo’ to make a fresh start in GSKThe most famous traditional vaccine company, GSK(GlaxoSmithKline), acquired product approval for ‘Menveo,’ the most domestically selling meningococcemia vaccine, from the 31st o...
|
The GLP-1 analogue insurance standard is largely improved
The GLP(glucagon-like peptide)-2 analogue, a diabetes treatment, has met a chance to be expanded in prescriptions by improvement of the health insurance standard.
The Ministry of Health and Welfare, on the 15th, has ...
First generic development of new antithrombotic drug, ‘Brilinta,’ has begun
Movements to develop the first generic of the AstraZeneca’s next-generation antithrombotic drug, Brilinta(generic name: ticagrelor), have been observed.
On the 14th, the Ministry of Food and Drug Safety approved bioe...
